Vitamin D receptor activation and survival in chronic kidney disease.

  title={Vitamin D receptor activation and survival in chronic kidney disease.},
  author={Csaba Pal Kovesdy and Kamyar Kalantar-Zadeh},
  journal={Kidney international},
  volume={73 12},
Replacement of activated vitamin D has been the cornerstone of therapy for secondary hyperparathyroidism (SHPT). Recent findings from several large observational studies have suggested that the benefits of vitamin D receptor activators (VDRA) may extend beyond the traditional parathyroid hormone (PTH)-lowering effect, and could result in direct cardiovascular and metabolic benefits. The advent of several new analogs of the activated vitamin D molecule has widened our therapeutic armamentarium… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 34 extracted citations

Vitamin D and Cardiovascular Disease: Controversy Unresolved.

Journal of the American College of Cardiology • 2017
View 1 Excerpt

Fibroblast growth factor 23 and bone mineralisation

International Journal of Oral Science • 2015

Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis • 2014
View 1 Excerpt

Fibroblast growth factor-23: what we know, what we don't know, and what we need to know.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…